Concepedia
1
Publications
35
Citations
H-Index
2019
Active since
Affiliations
Karyopharm Therapeutics (United States)(Current)
James Ge is an author at Karyopharm Therapeutics (United States).
Publications per year
2019–2019
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance
Husain Yar Khan, James Ge, Misako Nagasaka et al. · International Journal of Molecular Sciences · 2019 · 35 citations · Full text
Rows per page
1–1 of 1